Filter By:
December 11, 2018Client News
Gunderson Dettmer client InVision raises Series F

InVision, a digital design collaboration platform, has raised $115 million. The Series F round was led by Spark Capital with the participation of Goldman Sachs and existing investors including Battery Ventures, ICONIQ Capital, Tiger Global Management, FirstMark Capital and Geodesic Capital.

More
December 11, 2018Client News
Gunderson Dettmer client Plaid raises $250M Series C

Developer of financial and banking services platform, Plaid, raised $250 million in a Series C led by Kleiner Perkins with Spark Capital, New Enterprise Associates, Goldman Sachs and Index Ventures (UK) participating. The company is now valued at $2.65 billion, more than ten times its valuation in June 2016.

More
November 27, 2018Client News
Gunderson Dettmer client ChargePoint secures $240M Series H

ChargePoint, a client of Gunderson Dettmer, secured a Series H financing of $240 million bringing their total funding raised to more than half a million dollars. This round of funding comes from a diverse group of new investors including American Electric Power, Canada Pension Plan Investment Board, Chevron Technology Ventures, Clearvision, Daimler Trucks & Buses, GIC and Quantum Energy Partners. Existing investors include BMW iVentures, Braemar Energy Ventures, Linse Capital and Siemens.

More
November 13, 2018Client News
Gunderson Client Poynt Raises $100M

Poynt, a connected commerce platform for merchants, raised $100M in Series C funding from Elavon and National Australia Bank (NAB). As stated in the press release, "with this investment, the company will expand into new markets across Asia, Europe and South America, grow its talent base, and invest in product and partner development as it executes its vision to become the operating system (OS) on smart payment terminals worldwide."

More
October 11, 2018Client News
Gunderson Dettmer Advises Histogenics on Public Offering of Common Stock and Warrants

Gunderson Dettmer advised Histogenics Corporation on a follow-on public offering underwritten public offering of 26,155,000 shares of its common stock and warrants to purchase up to 19,616,250 shares of common stock, at a combined purchase price of $0.65 per share of common stock and accompanying warrant, for a total of $17,000,750.00 in aggregate gross proceeds.

More
October 10, 2018Client News
Gunderson Dettmer Advises Aldeyra Therapeutics on Public Offering

Gunderson Dettmer advised Aldeyra Therapeutics, Inc. on a follow-on public offering of 5,250,000 shares at the price to the public of $13.75 per share for a total of $72,187,500 in aggregate gross proceeds. Corporate partner Jay Hachigian, of counsel Keith Scherer, and associates Albert Vanderlaan, Naomi Smith and John Maciejewski led the team advising Aldeyra.

More
September 27, 2018Client News
Gunderson Dettmer Client Compass Raises $400M at $4.4B Valuation

Real estate platform Compass has raised $400 million in a Series F round of funding to help grow its domestic business as well as open internationally. The deal, led by Softbank’s Vision Fund and Qatar Investment Authority, has the company valued at $4.4 billion; double its valuation from last year.

More
July 31, 2018Client News
Gunderson Dettmer Advises SpringCM in $220 Million Acquisition by DocuSign

Gunderson Dettmer acted as legal advisor to SpringCM, a leading cloud-based document generation and contract lifecycle management software company, in its $220 million acquisition by DocuSign. In a definitive agreement announced today, the transaction will further accelerate DocuSign’s broadening of its solution beyond e-signature to the rest of the agreement process—from preparing to signing, acting-on, and managing agreements.  

More
May 10, 2018Client News
Gunderson Dettmer Advises ARMO BioSciences, Inc. in $1.6 Billion Acquisition by Eli Lilly and Company

Gunderson Dettmer acted as legal advisor to ARMO BioSciences (ARMO) in its $1.6 billion acquisition by Eli Lilly and Company (Lilly). In a definitive agreement announced today, the all-cash transaction will bolster Lilly’s immune-oncology program through the addition of ARMO’s lead product, pegilodecakin, which has demonstrated clinical benefit in multiple tumor types.

More
May 9, 2018Client News
Gunderson Dettmer Advises Flipkart in $16 Billion Deal, Making Walmart Inc. its Largest Shareholder

Gunderson Dettmer acted as international and M&A counsel to Flipkart in a $16 billion deal that will make Walmart Inc. its largest shareholder. Flipkart, which has been a client since 2011, is one of India’s largest e-commerce marketplaces and includes group companies Flipkart, Myntra, Jabong, and PhonePe. Launched in 2007, Flipkart has enabled millions of customers, sellers, merchants, and small businesses to be a part of India's e-commerce revolution, offering over 80 million products across 80+ categories.

More
March 12, 2018Client News
Despegar IPO recognized by IFLR Americans Awards 2018

Despegar's IPO was shortlisted for “Equity Deal of the Year” by IFLR Americas Awards 2018, after meeting its goal of raising $332 million. It was the first overseas initial public offering for an Argentine company in more than 16 months.

More
January 29, 2018Client News
Gunderson Dettmer advises Fullscreen in acquisition by Otter Media

Gunderson Dettmer represented Fullscreen in the buyout of the company’s remaining stakeholders. In 2014, controlling interest in Fullscreen was sold to Otter Media, a joint venture created by AT&T and The Chernin Group. AT&T is now buying out The Chernin Group as well as the minority stockholders in Fullscreen and another partially owned subsidiary.

More